Wound Complication Clinical Trial
— IMPARTOfficial title:
Incision Management With Prevena After Renal Transplant (IMPART) Trial: Negative Pressure Wound Therapy Versus Standard Dressings for Incision Management After Renal Transplant: a Multicentre, Partially-blinded Randomised Controlled Trial
This study is a multicentre, partially-blinded randomised controlled trial, with site
stratified block randomisation and partial blinding of outcome assessments. Patients
undergoing a renal transplant will be allocated to one of two treatment arms, where either a
Prevena device of appropriate size or standard dressing is applied to the closed incision. In
the case that a patient requires bilateral incisions, both incisions will be allocated to the
same treatment arm and counted as a single incision.
Primary:
The primary objective of this study is to determine if the Prevena Incision Management System
reduces wound complications at the surgical site following renal transplant, when compared to
standard dressings. Secondary: Secondary objectives of this study include identification of
risk factors for wound complications at the surgical site, as well as re-operation, prolonged
hospital stay, allograft survival, delayed graft function. This study will also assess pain,
scar healing and quality of life in each treatment arm, and aim to complete a cost-benefit
analysis of the Prevena device in renal transplantation.
Status | Recruiting |
Enrollment | 500 |
Est. completion date | September 2021 |
Est. primary completion date | May 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: The participant: 1. is an adult = 18 years old, regardless of comorbidities or BMI 2. is able to provide their own informed consent 3. will undergo open renal transplant surgery, including those who undergo dual renal transplant or simultaneous pancreas transplant. 4. will require a surgical incision(s) likely to be able to be covered completely by one or more Prevena Incision Management Systems. 5. is willing and able to return for the required follow up assessments. 6. if concurrently enrolled in a clinical trial it must not impact on patient health or the surgical incision site and the study must be documented Exclusion Criteria: The participant: 1. has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives. 2. Is not suitable for closure of the surgical wound, and as such the wound must be left open or an open NPWT device is required. 3. Is not willing to comply with the study procedures. 4. Has an unforseen intraoperative event mandating additional management including a planned re-exploration. 5. Has obvious intraoperative contamination of the surgical site. 6. Has a wound with suspected ischaemia in the incision area, or inadequate haemostasis. 7. Requires drains that cannot be covered by the Prevena dressing. |
Country | Name | City | State |
---|---|---|---|
Australia | Royal North Shore Hospital | Sydney | New South Wales |
Lead Sponsor | Collaborator |
---|---|
Royal North Shore Hospital |
Australia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Wound Complications | Any wound infection, wound dehiscence, wound haematoma, wound collection or re-operation due to the above following renal transplantation. | 0-90 days | |
Secondary | Length of hospital stay | Comparison of length of hospital stay between the two groups | 0-90 days | |
Secondary | Graft function (creatinine) | Comparison of markers of graft function (creatinine) between the two groups | 0-90 days | |
Secondary | Delayed graft function | Number of patients requiring ongoing dialysis in each group. | 0-90 days | |
Secondary | Pain score (numeric rating scale) | Comparison of patient reported post-operative wound pain scale between groups utilising a generic numeric rating scale (NRS) for pain. A numeric rating scale is a way a patient can report pain from 0-10, 0 being no pain, 10 being extreme pain. Minimum score is 0, maximum score is 10. It is better to have less pain, therefore 0 is the best score possible. |
0-90 days | |
Secondary | Scar quality (The Patient and Observer Scar Assessment Scale: POSAS) | Comparison of observer and patient reported scarring utilising the POSAS (The Patient and Observer Scar Assessment Scale: POSAS). The observer questions are listed below and are each scored from 1 to 10, 1 being normal skin, 10 being worst scar imaginable. Vascularity Pigmentation Thickness Relief Pliability Surface area Overall opinon of scar The patient scale questions are listed below and are each scored from 1 to 10, 1 being normal skin, 10 being the worst scar imaginable. 1. Has the scar been painful the past few weeks? 2. Has the scar been itching the past few weeks? 3. Skin Colour 4. Skin stiffness 5. Skin Thickness 6. Scar irregularity 7. Overall opinion of scar The total score for patient and observer subscales is out of 70 each, for a combined total of 140 (both subscales added together). The minimum possible score is 14 and the maximum score is 140. |
0-90 days | |
Secondary | Quality of Life (EQ-5D-5L score) | Comparison of quality of life scores reported by patients in each group using the EQ-5D-5L quality of life scale. The scale is split into 5 subscales; mobility self-care usual activities pain/discomfort anxiety/depression. Each subscale is ranked from 1 to 5, 1 being nil pain/quality of life disturbance, 5 being extreme pain/quality of life disturbance. The subscales are reported separately and are not combined. The patient also completes an overall health assessment from 0-100, 0 being the worst health imaginable, 100 being the best health imaginable. This is also reported and analysed separately. |
0-90days | |
Secondary | Graft function (estimated glomerular filtration rate) | Comparison of markers of graft function (creatinine) between the two groups | 0-90days | |
Secondary | ASEPSIS wound score | Wound scoring by a wound assessor. Scored: 0-5 for serous discharge and erythema (each), 0 being nil, 5 being significant. 0-10 for purulent exudate and separation of deep tissues (each), 0 being nil, 10 being significant. Isolation of bacteria on wound swap, 0 for no bacterial, 10 for bacterial growth. Further scores of 10 (for antibiotic usage), 5 (for drainage of pus under local anaesthesia), 10 (for debridement under general anaesthesia) and 5 (for prolonged inpatient stay >14 days). All scores are added together for a total of 70, 0 being the minimum possible (best) score and 70 being the maximum possible (worst) score. |
0-90days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01698372 -
Negative Pressure Dressing After Saphenous Vein Harvest
|
Phase 1 | |
Not yet recruiting |
NCT03872544 -
Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
|
||
Terminated |
NCT03148496 -
Tissue Reinforcement of Incisional Closure Among High Risk Patients
|
N/A | |
Enrolling by invitation |
NCT03880188 -
Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
|
||
Terminated |
NCT03269968 -
Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery
|
N/A | |
Active, not recruiting |
NCT03390764 -
Hernia After Colorectal Cancer Surgery
|
N/A | |
Completed |
NCT03938584 -
The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients
|
N/A | |
Completed |
NCT05142956 -
Smoking Increases the Risk of Postoperative Wound Complications: a Propensity Score-matched Cohort Study
|
||
Recruiting |
NCT03527433 -
Comparing Wound Complications After Elective Abdominal Surgery Using Two Closure Techniques
|
N/A | |
Completed |
NCT03477682 -
Postoperative Management of Groin Flaps for Vascular Coverage
|
N/A | |
Terminated |
NCT02838017 -
Tissue Adhesive vs. Sterile Strips After Cesarean Delivery
|
N/A | |
Not yet recruiting |
NCT02967627 -
VAC Dressings for Colorectal Resections
|
N/A | |
Completed |
NCT04735133 -
The Effect of Wound Problems Wound Dressing in Patients With Colorectal Cancer Surgery
|
N/A | |
Completed |
NCT03942575 -
The Risk of Postoperative Wound Complications Following the Use of Negative Pressure Wound Therapy in Patients Undergoing Mastectomy
|
N/A | |
Not yet recruiting |
NCT06191159 -
Cosmetic Outcome of Electrocautery, Scalpel and PEAK PlasmaBlade for Surgical Breast Incisions
|
N/A | |
Terminated |
NCT02355691 -
Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty
|
N/A | |
Completed |
NCT02128997 -
PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population
|
N/A | |
Completed |
NCT01977612 -
Randomized Clinical Trial of Skin Closure With Staples Versus Suture
|
Phase 2 | |
Completed |
NCT03061903 -
Closed Incision Negative Pressure Therapy vs Standard of Care
|
N/A | |
Not yet recruiting |
NCT06337292 -
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures: A Multicenter Randomized Controlled Trial
|
Phase 3 |